FOLH1 and Familial prostate cancer: - Performance of PSMA PET/MR to MR alone at staging prostate cancer- Performance of PSMA PET/MR to MR alone for identification of dominant intraprostatic nodules during radiation planning- Compare imaging biomarkers of interest on MR and PSMA PET/MR as predictors of treatment response, versus biopsy of treatment response and PSA- Compare imaging biomarkers of interest on MR and PSMA PET/MR as predictors of treatment response, versus biopsy of treatment response and PSA